Skip to main content

Vanderbilt Center for Neuroscience Drug Discovery Archives

Grant enhances mental illness drug research efforts

Jul. 16, 2015—Research at Vanderbilt University Medical Center aimed at developing potential new treatments for major depressive disorder, general anxiety disorder and post-traumatic stress disorder got a big boost this week from The William K. Warren Foundation of Tulsa, Oklahoma.

Read more


Findings reveal new target in quest to ease schizophrenia

May. 7, 2015—Vanderbilt University researchers have uncovered a surprising finding that could lead to the development of new, more effective therapies for schizophrenia, which affects more than 2 million Americans.

Read more


Grant spurs schizophrenia research

Feb. 12, 2015—Vanderbilt University is partnering with the William K. Warren Foundation of Tulsa, Oklahoma, on research aimed at improving the treatment of schizophrenia and other forms of serious mental illness.

Read more


Schizophrenia ‘switches’ discovered

Sep. 12, 2014—Drugs developed at Vanderbilt could provide a new way to treat schizophrenia in a personalized way.

Read more


‘Missing link’ may spur new brain disorder drugs

Mar. 13, 2014—Researchers at the Scripps Research Institute in San Diego and Vanderbilt University have discovered a “missing link” in the structure of a transmembrane receptor that could lead to new treatments for autism, schizophrenia, Parkinson’s disease and Alzheimer’s disease.

Read more


Newsmakers: Vanderbilt’s teaching, research and patient care efforts are making an impact

May. 6, 2013—These stories from the past year show how Vanderbilt is making an impact, on campus and in the world.

Read more


Lindsley honored for impact on medicinal chemistry field

Mar. 14, 2013—Vanderbilt University’s Craig Lindsley, Ph.D., is the 2013 recipient of the Philip S. Portoghese Lectureship, awarded jointly by the Journal of Medicinal Chemistry and the American Chemical Society (ACS) Division of Medicinal Chemistry.

Read more


Pharmacology society honors Limbird’s impact

Jan. 24, 2013—Vanderbilt University’s Lee Limbird, Ph.D., has received one of pharmacology’s highest honors — the 2013 Julius Axelrod Award from the American Society for Pharmacology and Experimental Therapeutics (ASPET).

Read more


AstraZeneca, VU collaborate to develop new treatments for major brain disorders

Jan. 14, 2013—AstraZeneca and Vanderbilt University have signed a research collaboration agreement to identify candidate drugs aimed at treating psychosis and other neuropsychiatric symptoms associated with major brain diseases such as Alzheimer’s disease and schizophrenia.

Read more


Nobel in Chemistry reveals VU ties that bind

Oct. 18, 2012—Several Vanderbilt researchers have collaborated with this year's Nobel Chemistry winners.

Read more


Insights for neuroscience drug discovery

Jul. 17, 2012—When discovering drugs for brain disorders, it’s important to test the candidates in multiple ways to avoid advancing those with restricted physiological effects.

Read more


Vanderbilt expanding research enterprise into Williamson County

Mar. 9, 2012—With the addition of a new 18,000-square-foot laboratory to be located within the Cool Springs Life Sciences Center, Vanderbilt University is expanding its research enterprise into Williamson County.

Read more


Page 2 of 3123

Upcoming Events

MORE EVENTS »